Growth Suppression of HER2-Overexpressing Breast Cancer Cells by Berberine via Modulation of the HER2/PI3K/Akt Signaling Pathway

doi:10.1021/jf2012584

淡江大學機構典藏 > 理學院 > 化學學系暨研究所 > 期刊論文 > Item 987654321/89026

請使用永久網址來引用或連結此文件: https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/89026

題名:	Growth Suppression of HER2-Overexpressing Breast Cancer Cells by Berberine via Modulation of the HER2/PI3K/Akt Signaling Pathway
作者:	Kuo, Han-Peng;Chuang, Tzu-Chao;Yeh, Ming-Han;Hsu, Shih-Chung;Way, Tzong-Der;Chen, Po-Yuan;Wang, Shan-Shue;Chang, Yung-Hsien;Kao, Ming-Ching;Liu, Jah-Yao
貢獻者:	淡江大學化學學系
關鍵詞:	berberine;breast cancer;HER2;PI3K/Akt signaling cascade;apoptosis;cell cycle arrest
日期:	2011
上傳時間:	2013-05-03 16:37:41 (UTC+8)
出版者:	Washington, DC: American Chemical Society
摘要:	Berberine (BBR) is a natural alkaloid with significant antitumor activities against many types of cancer cells. This study investigated the molecular mechanisms by which BBR suppresses the growth of HER2-overexpressing breast cancer cells. The results show that BBR induces G1-phase cell cycle arrest by interfering with the expression of cyclins D1 and E and that it induces cellular apoptosis through the induction of a mitochondria/caspase pathway. The data also indicate that BBR inhibits cellular growth and promotes apoptosis by down-regulating the HER2/PI3K/Akt signaling pathway. Furthermore, it is also shown that a combination of taxol and BBR significantly slows the growth rate of HER2-overexpressing breast cancer cells. In conclusion, this study suggests that BBR could be a useful adjuvant therapeutic agent in the treatment of HER2-overexpressing breast cancer.
關聯:	Journal of Agricultural and Food Chemistry 59(15), pp.8216–8224
DOI:	10.1021/jf2012584
顯示於類別:	[化學學系暨研究所] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
Growth Suppression of HER2-Overexpressing Breast Cancer Cells by Berberine via Modulation of the HER2 PI3K Akt Signaling Pathway.pdf		3365Kb	Adobe PDF	1	檢視/開啟
index.html		0Kb	HTML	69	檢視/開啟

在機構典藏中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....